A long-awaited case involving transvaginal mesh maker C.R. Bard is once again delayed – this time indefinitely.

A long-awaited case involving transvaginal mesh maker C.R. Bard is once again delayed – this time indefinitely.
Thousands of C.R. Bard vaginal mesh cases are being consolidated into one mass tort case, and the company continues to see challenges arise regarding ongoing litigation.
Numerous mass tort cases against transvaginal mesh manufacturers is set to be heard in 2014.
There are many ways to alleviate transvaginal mesh symptoms.
There are distinct differences between transvaginal mesh and vaginal slings.
As much as 50 percent of women who have had a child develop pelvic organ prolapse – the most common reason women turn to surgical mesh implants that have caused serious complications and resulted in thousands filing lawsuits against the makers of the medical device.
Women don’t have to undergo surgery to have relief from their urinary incontinence.
A woman in Britain had an operation in 2007 to have transvaginal mesh implanted but was left in pain and forced to use a wheelchair for five years.
As complications from transvaginal mesh come into the spotlight, more physicians may seek resources about the products to ensure their patients remain safe.
Boston Scientific, one of various transvaginal mesh manufacturers facing lawsuits, recently saw its chief financial officer and six other executives sell almost 1 million shares in the company.